BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12385589)

  • 21. Adenocarcinoma of the uterine cervix with predominantly villogladular papillary growth pattern.
    Kaku T; Kamura T; Shigematsu T; Sakai K; Nakanami N; Uehira K; Amada S; Kobayashi H; Saito T; Nakano H
    Gynecol Oncol; 1997 Jan; 64(1):147-52. PubMed ID: 8995564
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Villoglandular papillary adenocarcinoma of the uterine cervix: report of a case.
    Borgo G; Feyles E; Gaglio A; Tagliani L; Andrion A
    Tumori; 1998; 84(6):717-9. PubMed ID: 10080684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Term delivery following conservative treatment for villoglandular papillary adenocarcinoma of the uterine cervix: report of a case and analysis of the literature.
    Hoffman JS; Bazzurini L; Laird L; Murphy JC; Magriples U; Lewis J
    Gynecol Oncol; 2001 May; 81(2):310-3. PubMed ID: 11330967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Villoglandular adenocarcinoma of the cervix: a report of three cases and review of the literature.
    Stanley-Christian H; Heim BK; Hines JF; Hall KL; Willett GD; Barnes WA
    Gynecol Oncol; 1997 Aug; 66(2):327-30. PubMed ID: 9264585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocervical adenocarcinomas with prominent endometrial or endomyometrial involvement simulating primary endometrial carcinomas: utility of HPV DNA detection and immunohistochemical expression of p16 and hormone receptors to confirm the cervical origin of the corpus tumor.
    Yemelyanova A; Vang R; Seidman JD; Gravitt PE; Ronnett BM
    Am J Surg Pathol; 2009 Jun; 33(6):914-24. PubMed ID: 19295407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
    Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
    Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of pelvic lymph node micrometastasis in stage IA2-IB2 cervical cancer by immunohistochemical analysis.
    Juretzka MM; Jensen KC; Longacre TA; Teng NN; Husain A
    Gynecol Oncol; 2004 Apr; 93(1):107-11. PubMed ID: 15047221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of patients after extraperitoneal lymph node dissection for cervical cancer.
    Denschlag D; Gabriel B; Mueller-Lantzsch C; Tempfer C; Henne K; Gitsch G; Hasenburg A
    Gynecol Oncol; 2005 Mar; 96(3):658-64. PubMed ID: 15721408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Villoglandular papillary adenocarcinoma of the cervix: case report.
    Lakhtakia R; Singh MK; Taneja P; Kapila K; Kumar S
    J Surg Oncol; 2000 Aug; 74(4):297-9. PubMed ID: 10962465
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Verrucous carcinoma of the cervix: detection of carcinogenetic human papillomavirus types and their role during follow-up.
    Frega A; Lukic A; Nobili F; Palazzo A; Iacovelli R; French D; Moscarini M
    Anticancer Res; 2007; 27(6C):4491-4. PubMed ID: 18214065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytologic features of villoglandular adenocarcinoma of the cervix.
    Ajit D; Dighe S; Gujral S
    Acta Cytol; 2004; 48(2):288-9. PubMed ID: 15085771
    [No Abstract]   [Full Text] [Related]  

  • 32. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix: a case report.
    Lu FH; Chen BF; Yang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Jul; 61(7):436-40. PubMed ID: 9699398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Villoglandular papillary adenocarcinoma of the uterine cervix responding to neoadjuvant chemotherapy with docetaxel and cisplatin: a case report.
    Nagai N; Hirata E; Kusuda T; Mukai K; Arihiro K; Ohama K
    Int J Gynecol Cancer; 2005; 15(6):1187-90. PubMed ID: 16343210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis.
    dos Reis R; Frumovitz M; Milam MR; Capp E; Sun CC; Coleman RL; Ramirez PT
    Gynecol Oncol; 2007 Dec; 107(3):458-63. PubMed ID: 17854872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
    Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
    Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesonephric adenocarcinoma of the uterine cervix: a case report with immunohistochemical and ultrastructural studies.
    Fukunaga M; Takahashi H; Yasuda M
    Pathol Res Pract; 2008; 204(9):671-6. PubMed ID: 18374498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poor prognosis of patients with stage Ib1 adenosquamous cell carcinoma of the uterine cervix with pelvic lymphnode metastasis.
    Yasuda S; Kojima A; Maeno Y; Oki N; Miyahara Y; Sudo T; Takekida S; Yamaguchi S; Nishimura R
    Kobe J Med Sci; 2006; 52(1-2):9-15. PubMed ID: 16547424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serous adenocarcinoma of the uterus: criteria of morphological diagnosis and immunohistochemistry].
    Vasil'eva EV; Belianin VL
    Arkh Patol; 2005; 67(2):25-7. PubMed ID: 15938115
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Villoglandular adenocarcinoma of the vulva.
    Rodriguez A; Isaac MA; Hidalgo E; Márquez B; Nogales FF
    Gynecol Oncol; 2001 Nov; 83(2):409-11. PubMed ID: 11606106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conservative surgical management of small-volume stage IB1 cervical cancer.
    Naik R; Cross P; Nayar A; Mayadevi S; Lopes A; Godfrey K; Hatem H
    BJOG; 2007 Aug; 114(8):958-63. PubMed ID: 17578471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.